Pronađeno: 1-5 / 5 radova

Autori: Purkalne Gunta

>> Filter: Samo Article i Review

>> Sve godine

Naslov FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study (Article)
Autori Brodowicz Thomas Ciuleanu Tudor E Radosavljevic Davorin Z Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Messinger D Zielinski Christoph 
Info ANNALS OF ONCOLOGY, (2013), vol. 24 br. 7, str. 1769-1777
Projekat CECOG
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) (Meeting Abstract)
Autori Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Brodowicz Thomas Zielinski Christoph 
Info JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 15, Suppl. S, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). (Meeting Abstract)
Autori Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank Magdolna Purkalne Gunta Brodowicz Thomas Zielinski Christoph 
Info JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 4, Suppl. S, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cetuximab Weekly (Q1W) Versus Every Two Weeks (Q2W) Plus Folfox4 as First-line Therapy in Patients (PTS) with Kras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) (Meeting Abstract)
Autori Ciuleanu Tudor E Nikolic Vladimir Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Kahan Zsuzsanna Purkalne Gunta Brodowicz Thomas Zielinski Christoph 
Info ANNALS OF ONCOLOGY, (2011), vol. 22 br. , Suppl. Suppl. 5, str. v22-v22
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers (Editorial Material)
Autori Elsakov Pavel Foretova Lenka Goetz Petr de Groot Johannes WB van der Graaf Winette TA Guler Gulnur Huebner Kay Haites Neva E Hamann Ute Ho Judy Imyanitov Evgeny N Irmejs Arvids Purkalne Gunta Bitina Marianna Gardovskis Andris Gardovskis Janis Kirova Youlia M Fourquet Alain Pierga Jean-Yves Stoppa-Lyonnet Dominique Larizza Lidia Lips Cornelis JM Loman Niklas Borg Ake Moller Pal Olsson Hakan Park Jae-Gahb Radulovic Sinisa S Brankovic-Magic Mirjana V  Rajkumar Thangarajan Razis Evangelia Yannoukakos Drakoulis Schmitt Fernando Schmutzler Rita Simmonds Peter D Eccles Diana Smeltzer Jacob Silberstein Peter T Lynch Henry Weber Walter Willemse Pax HB Sijmons Rolf H Wysocki Piotr J Zajac Vladimir Shu Zheng 
Info HEREDITY CANCER IN CLINICAL PRACTICE, (2007), vol. 5 br. 3, str. 119-143
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX